Blackstone Inc Autolus Therapeutics PLC Transaction History
Blackstone Inc
- $24.2 Billion
- Q1 2024
A detailed history of Blackstone Inc transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Blackstone Inc holds 20,485,611 shares of AUTL stock, worth $71.3 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
20,485,611
Previous 20,485,611
-0.0%
Holding current value
$71.3 Million
Previous $132 Million
0.93%
% of portfolio
0.54%
Previous 0.61%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
123Shares Held
168MCall Options Held
411KPut Options Held
67.6K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$74.3 Million90.76% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$53.1 Million3.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$43 Million0.95% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$37.5 Million0.01% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E97.53MShares$26.2 Million16.27% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $316M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...